𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection

✍ Scribed by W. Jessner; T. Watkins-Riedel; C. Müller; E. Formann; M. Gschwantler; P. Ferenci

Book ID
108886022
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
179 KB
Volume
14
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of the clinical usefulness of
Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level
✍ Shigenobu Kawai; Osamu Yokosuka; Fumio Imazeki; Hiromitsu Saisho; Chitose Mizuno 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract The quantitation of serum levels of hepatitis C virus (HCV) RNA in chronic hepatitis C has been regarded as one of the most important indicators for the outcome of interferon (IFN) therapy. The AMPLICOR HCV MONITOR version 1.0 (AMPLICOR v1.0) assay is widely used for the evaluation of t

Effect of genotypes on the quantificatio
Effect of genotypes on the quantification of hepatitis C virus (HCV) RNA in clinical samples using the amplicor HCV monitor test and the quantiplex HCV RNA 2.0 assay (bDNA)
✍ Tong, C. Y. W.; Hollingsworth, R. C.; Williams, H.; Irving, W. L.; Gilmore, I. T 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

The Amplicor HCV Monitor test and the Quantiplex HCV RNA 2.0 (bDNA) assay are two commercially available assays for the quantification of hepatitis C virus (HCV) RNA in clinical samples. A direct comparison of the two assays was carried out using sera frozen previously from patients known to be chro